Research Topics
| Michael K GouldSummaryAffiliation: Stanford University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their livesJeffrey J Swigris
Division of Pulmonary Medicine, National Jewish Medical and Research Center, Denver, CO, USA
Health Qual Life Outcomes 3:61. 2005..On a broader scale, to provide the best care for people with IPF, clinicians must appreciate--from patients' perspectives--how this disease affects various aspects of their lives...- A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodulesMichael K Gould
Veterans Affairs Palo Alto Health Care System, 3801 Miranda Ave 111P, Palo Alto, CA 94304, USA
Chest 131:383-8. 2007..Estimating the clinical probability of malignancy in patients with a solitary pulmonary nodule (SPN) can facilitate the selection and interpretation of subsequent diagnostic tests... 
Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition)Michael K Gould
VA Palo Alto Health Care System, 3801 Miranda Ave 111P, Palo Alto, CA 94304, USA
Chest 132:108S-130S. 2007..Identification of malignant nodules is important because they represent a potentially curable form of lung cancer...- Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodulesMichael K Gould
Pulmonary Section, Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue, Palo Alto, California 94304, USA
Ann Intern Med 138:724-35. 2003..Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) is a potentially useful but expensive test to diagnose solitary pulmonary nodules... - Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysisM K Gould
Pulmonary and Critical Care Section, Veterans Affairs Palo Alto Health Care System, California 94304, USA
Ann Intern Med 130:789-99. 1999..Low-molecular-weight heparins are effective for treating venous thrombosis, but their cost-effectiveness has not been rigorously assessed... 
Timeliness of care in veterans with non-small cell lung cancerMichael K Gould
Veterans Affairs Palo Alto Health Care System, 3801 Miranda Ave 111P, Palo Alto, CA 94304, USA
Chest 133:1167-73. 2008..Timeliness is an important dimension of quality of care for patients with lung cancer...- Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysisM K Gould
Pulmonary Section 111P, VA Palo Alto Health Care System, 3801 Miranda Ave, Palo Alto, CA 94304, USA
JAMA 285:914-24. 2001..Focal pulmonary lesions are commonly encountered in clinical practice, and positron emission tomography (PET) with the glucose analog 18-fluorodeoxyglucose (FDG) may be an accurate test for identifying malignant lesions... - Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trialsM K Gould
Pulmonary and Critical Care Medicine Section, Veterans Affairs Palo Alto Health Care System, California 94304, USA
Ann Intern Med 130:800-9. 1999..Low-molecular-weight heparins may simplify the management of deep venous thrombosis. A critical clinical issue is whether this more convenient therapy is as safe and effective as treatment with unfractionated heparin... - Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysisMichael K Gould
Pulmonary Section 111P, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304, USA
Ann Intern Med 139:879-92. 2003.... - Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) studyMichael K Gould
VA Palo Alto Health Care System, Palo Alto, California, USA
J Thorac Oncol 6:875-83. 2011..Disparities in treatment exist for nonwhite and Hispanic patients with non-small cell lung cancer, but little is known about disparities in the use of staging tests or their underlying causes... - The cost of positron emission tomography in six United States Veterans Affairs hospitals and two academic medical centersMagdalena Berger
VA Palo Alto Health Care System, VA Cooperative Studies Program Coordinating Center, VA HSR and D Health Economics Resource Center, Menlo Park, CA 94025, USA
AJR Am J Roentgenol 181:359-65. 2003..Because both PET and cyclotron facilities have high fixed costs, increasing the number of scans obtained and the number of FDG doses manufactured may lead to a decrease in unit costs... - Minimally invasive techniques for the diagnosis of peripheral pulmonary nodulesGanesh Krishna
VA Palo Alto Healthcare System, Stanford University School of Medicine, California 94304, USA
Curr Opin Pulm Med 14:282-6. 2008..Evaluation and management of patients with pulmonary nodules continue to be a significant clinical challenge due to the possibility of malignancy... - Lung cancer incidence in never smokersHeather A Wakelee
Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, USA
J Clin Oncol 25:472-8. 2007..However, data on this topic, particularly lung cancer incidence rates in never smokers, are limited... - Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient dataJon Erik C Holty
Center for Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA
Liver Transpl 15:894-906. 2009..Liver Transpl 15:894-906, 2009. (c) 2009 AASLD... - Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failureJoseph E Levitt
Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA
Chest 135:936-43. 2009..To establish a definition of early ALI (EALI), we carried out a prospective cohort study to identify clinical predictors of progression to ALI... - The pathogenetic and prognostic value of biologic markers in acute lung injuryJoseph E Levitt
Division of Pulmonary Critical Care, Stanford University, Stanford, California 94305, USA
J Intensive Care Med 24:151-67. 2009..This article provides a review of biologic markers in acute lung injury, with an emphasis on recent analysis of results from multicenter clinical trials... - Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniquesWilliam T Kuo
Division of Vascular and Interventional Radiology, Department of Radiology, Stanford University Medical Center, 300 Pasteur Dr, H 3630, Stanford, CA 94305 5642, USA
J Vasc Interv Radiol 20:1431-40. 2009..The authors used evidence-based methods to evaluate the safety and effectiveness of modern catheter-directed therapy (CDT) as an alternative treatment for massive PE... - Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic reviewViswam S Nair
Divisions of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
J Thorac Oncol 4:1473-9. 2009..We aimed to investigate the association between tumor FDG uptake and survival in patients with surgically resected, stage I NSCLC... - PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancerViswam S Nair
Stanford University School of Medicine, Division of Pulmonary and Critical Care Medicine, 300 Pasteur Dr, A283, Stanford, CA 94305, USA
Chest 137:1150-6. 2010..Our objective was to examine the association between (18)F-fluorodeoxyglucose (FDG) uptake on PET scan and prognosis in patients with surgically treated, clinical stage IA non-small cell lung cancer (NSCLC)... - Length of stay predictions: improvements through the use of automated laboratory and comorbidity variablesVincent Liu
Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA 94305, USA
Med Care 48:739-44. 2010..Most methods for risk-adjusting LOS are limited by the use of only administrative data. Recent studies suggest that adding automated clinical data to these models improves performance... - Variation in experts' beliefs about lung cancer growth, progression, and prognosisEllen M Schultz
Center for Primary Care and Outcomes Research PCOR, 117 Encina Commons, Stanford, CA 94305, USA
J Thorac Oncol 3:422-6. 2008..Little is known about the natural history of malignant solitary pulmonary nodules (SPN). Experts' beliefs may help fill these knowledge gaps and explain variation in clinical practices... - Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic reviewAnnette Langer-Gould
Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA 94305, USA
Arch Neurol 63:1686-91. 2006..To identify clinical and demographic factors associated with long-term disability in patients with relapsing-remitting multiple sclerosis... - Health-related quality of life among patients with idiopathic pulmonary fibrosisJeffrey J Swigris
Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, CA 94305 5236, USA
Chest 127:284-94. 2005.... - Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigatorJeffrey J Swigris
Division of Pulmonary and Critical Care Medicine, Stanford University, Medical Center, Stanford, CA 94305 5236, USA
Chest 127:275-83. 2005.... - Usefulness of positron emission tomography imaging in the management of lung cancerP S Sarinas
Division of Pulmonary and Critical Care Medicine, VA Palo Alto Health Care System, California, USA
Curr Opin Pulm Med 5:201-7. 1999..Positron emission tomography may also predict prognosis. This review discusses the uses of positron emission tomography, the current literature, and the clinical guidelines for positron emission tomography imaging... - Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodulesE M Schultz
Stanford School of Medicine, Stanford, CA 94305, USA
Thorax 63:335-41. 2008..Effective strategies for managing patients with solitary pulmonary nodules (SPN) depend critically on the pre-test probability of malignancy... - Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysisJ E C Holty
VA Palo Alto Health Care System, CA, USA
Thorax 60:949-55. 2005..The reported accuracy of transbronchial needle aspiration (TBNA) for mediastinal staging in non-small cell lung cancer (NSCLC) varies widely. We performed a meta-analysis to estimate the accuracy of TBNA for mediastinal staging in NSCLC... - Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic reviewJ J Swigris
Stanford University Medical Center, Division of Pulmonary and Critical Care Medicine, MC5236, Room H3143, 300 Pasteur Drive, Stanford, CA 94305 5236, USA
Thorax 60:588-94. 2005..A systematic review was performed to evaluate critically the published literature and to examine what is known about health-related quality of life (HRQL) in patients with IPF... - Meta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosisSmita Nayak
VA Palo Alto Health Care System, Palo Alto, California, USA
Ann Intern Med 144:832-41. 2006..However, there is no consensus regarding its accuracy for identifying patients with osteoporosis... - Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocolJuliana Barr
Department of Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA
Chest 125:1446-57. 2004..To determine whether the implementation of a nutritional management protocol in the ICU leads to the increased use of enteral nutrition, earlier feeding, and improved clinical outcomes in patients... - Timeliness of care in patients with lung cancer: a systematic reviewJ K Olsson
VA Palo Alto Health Care System, Palo Alto, CA 94304, USA
Thorax 64:749-56. 2009..Timeliness is an important dimension of health care quality. It is unclear whether timeliness improves clinical outcomes in patients with lung cancer... - Lung cancer screening debateMichael K Gould
Chest 123:653-4; author reply 654-5. 2003 - Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumoniaRobert A Fowler
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, USA
Chest 123:835-44. 2003.... - Multidisciplinary management of lung cancerMichael K Gould
N Engl J Med 350:2008-10; author reply 2008-10. 2004 - CT screening for lung cancerMichael K Gould
N Engl J Med 356:743; author reply 746-7. 2007 - Utility of CT for predicting pulmonary hypertension in patients with parenchymal lung disease: similar results, different conclusion?Hubert Chen
Chest 133:1053-4; author reply 1054. 2008 - A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancerShirin Shafazand
Division of Pulmonary and Critical Care Medicine, University of Miami, Miller School of Medicine, Miami, Florida 33101, USA
J Thorac Oncol 1:953-9. 2006..Estimating the clinical probability of mediastinal metastasis in patients with non-small cell lung cancer (NSCLC) can facilitate the selection and interpretation of staging tests... - Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition)Gerard A Silvestri
Medical University of South Carolina, Department of Pulmonary and Critical Care Medicine, 171 Ashley Ave, Room 812 CSB, Charleston, SC 29425 2220, USA
Chest 132:178S-201S. 2007..Several noninvasive imaging studies including chest CT scanning and positron emission tomography (PET) scanning are available. Understanding the test characteristics of these noninvasive staging studies is critical to decision making... - Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition)Momen M Wahidi
Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Box 3683, Durham, NC 27710, USA
Chest 132:94S-107S. 2007..The solitary pulmonary nodule (SPN) is a frequent incidental finding that may represent primary lung cancer or other malignant or benign lesions. The optimal management of the SPN remains unclear... - Variability in the use of thromboprophylaxis and outcomes in critically ill medical patientsKrista L Lentine
Department of Medicine, Center for Outcomes Research and Division of Nephrology, Saint Louis University School of Medicine, St Louis, MO 63104, USA
Am J Med 118:1373-80. 2005..To describe practices for preventing venous thromboembolism in critically ill medical patients and to identify associations between prophylactic measures and survival... - Asthma control, severity, and quality of life: quantifying the effect of uncontrolled diseaseHubert Chen
Department of Medicine, The University of California San Francisco, USA
J Allergy Clin Immunol 120:396-402. 2007..Current practice guidelines emphasize the importance of attaining asthma control. We sought to quantify the degree of quality-of-life impairment associated with different levels of asthma control... - Validity of standard gamble utilities as measured by transplant readiness in lung transplant candidatesLianne G Singer
Department of Medicine, University Health Network, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Med Decis Making 23:435-40. 2003..To evaluate the validity of standard gamble (SG) utilities, by comparing utilities with decision-making behavior in a group of lung transplant candidates facing a risky health decision... - Poor choice of primary outcome in a clinical trial of pirfenidone in patients with IPFJoseph Levitt
Am J Respir Crit Care Med 172:1228-9; author reply 1229. 2005 - Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolismDaniella J Perlroth
Department of Medicine, School of Medicine, Stanford University, Stanford, California, USA
Arch Intern Med 167:74-80. 2007..Thrombolytic therapy is controversial in patients with submassive pulmonary embolism... - Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition)Stephen G Spiro
Department of Respiratory Medicine, University College Hospital, Grafton Way, London WC1E 6AU, UK
Chest 132:149S-160S. 2007..This chapter of the guidelines is intended to provide an evidence-based assessment of the initial evaluation of patients recognized as having lung cancer and the recognition of paraneoplastic syndromes... - Health-related quality of life in patients with pulmonary arterial hypertensionShirin Shafazand
The George Washington University, Washington Hospital Center, Washington, DC, USA
Chest 126:1452-9. 2004..This study describes HRQOL in a cohort of patients with PAH... - Effectiveness and cost effectiveness of thrombolysis in patients with acute pulmonary embolismRoham T Zamanian
Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California, USA
Curr Opin Pulm Med 14:422-6. 2008..As prompt anticoagulation is the mainstay of therapy in patients with pulmonary embolism, the clinical utility and cost effectiveness of systemic thrombolysis is debated... - Preventing venous thromboembolism in the intensive care unit: A no-brainer?Michael K Gould
J Crit Care 20:304-5. 2005 - An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendationsHolger J Schunemann
Am J Respir Crit Care Med 174:605-14. 2006 - Determinants of health utility in lung and heart-lung transplant recipientsLianne G Singer
Department of Medicine, University Health Network, University of Toronto, Toronto, Canada
Am J Transplant 5:103-9. 2005..Although BOS is a major determinant of utility following lung and heart-lung transplantation, other demographic and clinical factors are also associated with significant differences in this measure of HRQL...